Total Neoadjuvant Treatment in Oesophageal Adenocarcinoma: The TNT OAC Trial
We are hoping to open a phase 2 trial comparing outcomes in patients with resectable oesophageal and gastro-oesophageal junction adenocarcinoma receiving two different total neoadjuvant treatment regimens early next year (TNT-OAC).
Patients will receive either extended FLOT total neoadjuvant therapy or FLOT + CROSS total neoadjuvant therapy. We will also be carrying out translational research on tissue from recruited patients. More information can be found in the trial synopsis - click here to view more
We would be very grateful for your reply to the feasibility survey for the study at this link: https://www.surveymonkey.co.uk/r/TNT-OAC
Please do not hesitate to contact us if you have any questions.
Hollie Clements, Tim Underwood, Russell Petty